Health Care & Life Sciences » Pharmaceuticals | Hyundai Pharmaceutical Co. Ltd.

Hyundai Pharmaceutical Co. Ltd.

Hyundai Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW40.93
Market Cap
KRW131.7 B
Shares Outstanding
32 M
Public Float
19.34 M

Profile

Address
55 Jandari-gil
Cheonan SC 31213
Korea, Republic Of
Employees -
Website http://www.hyundaipharm.co.kr
Updated 07/08/2019
Hyundai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products, health food drinks and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.

Financials

View All
Created with Highcharts 5.0.14Hyundai Pharmaceutical Co. Ltd.Net Income. Fiscal year is December-November. All values KRW Millions.1 4151 4151 4681 4681 5941 5941 3971 3971 4581 4581 1201 1202013201420152016201720180500100015002000
Created with Highcharts 5.0.14Hyundai Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is December-November. All values KRW Millions.108 135108 135107 837107 837109 829109 829120 022120 022130 480130 480133 943133 943201320142015201620172018025k50k75k100k125k150k

Han-Gu Lee
Chairman & Co-Chief Executive Officer
Young-Hak Kim
President, Co-Chief Executive Officer & Director